XML 48 R37.htm IDEA: XBRL DOCUMENT v3.21.1
Share-Based Compensation - Additional Information (Details) - USD ($)
1 Months Ended 3 Months Ended
Mar. 27, 2020
Jun. 30, 2020
Mar. 31, 2020
Feb. 29, 2020
Mar. 31, 2021
Mar. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Allocated Share-based Compensation Expense       $ 70,000,000 $ 130,000 $ 588,000
Restricted Stock Units (RSUs) [Member]            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Allocated Share-based Compensation Expense       4,000,000    
Performance Shares [Member]            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized         243,532  
Share Based Compensation Arrangement By Share Based Payment Award Unrecognized Compensation Costs         $ 0  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number         338,663  
Allocated Share-based Compensation Expense         $ 800,000  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number         338,663  
Number of options outstanding at September 30, 2020         338,663  
Common Stock Awards [Member]            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 9,795   35,000      
Allocated Share-based Compensation Expense     $ 74,800,000      
Number of awards issued 9,795   35,000      
Number of common shares whose milestone were achieved 15,000          
Number of fully vested shares withheld 5,205          
Expense to be recognized upon the achievement of certain milestones     $ 65,200,000     $ 65,200,000
Chief Financial Officer [Member]            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Allocated Share-based Compensation Expense       153,000,000    
Stock options issued       $ 80,000,000    
Number of options to purchase common stock modified       236,970    
Chief Financial Officer [Member] | Restricted Stock Units (RSUs) [Member]            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Number of awards whose vesting was accelerated       3,300    
Biostage Amended and Restated Equity Incentive Plan            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period         4 years  
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period         10 years  
Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized   3,000,000        
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized   5,098,000        
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized         $ 300,000  
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition         3 months 18 days  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value         $ 0  
Share Price         $ 1.34  
Shares available for issuance         3,461,091